Prilocain

local anesthetic active pharmaceutical ingredient

Dimethisoquin hydrochloride

local anesthetic active pharmaceutical ingredient

Iohexol EP Impurity E

pharmaceutical reference standard

N-(1-(8-((3-methyl-4-((1-methyl-1H-benzo[d]imidazol-5-yl)oxy)phenyl)amino)pyrimido[5,4-d]pyrimidin-2-yl)piperidin-4-yl)acrylamide

selective irreversible HER2 tyrosine kinase inhibitor

MRE-269 1-N-Oxide

prostacyclin receptor agonist metabolite

4-((4-(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl)oxy)-1-(4-fluorophenyl)butan-1-one

pharmaceutical intermediate